← All trials
NCT04491526
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2020
- Primary completion
- Dec 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Jul 29, 2020
- Last posted
- Jul 29, 2020
- Enrollment
- 634
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Kantonsspital BadenLead sponsor
- Becton DickinsonCollaborator
- Kantonsspital BadenSponsor investigator
- Kantonsspital BadenOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.